Today, I list small cap companies I believe are top acquisition targets for large pharma. I combine speculation, rumors and buzz I am hearing, and company financial position as a few factors for consideration. Buy-outs are hard to predict in…
Month: May 2013
Updated:Trade Call Opinion: $TSRX For a Bounce Back Over $8
Today TSRX bounced off about $7.50 again, which has proven to be a solid level of support. On the below 60 minute, 20-day chart we can see that it is setting up to make a move to back around $8.00…
Long Trade Call: Five Star Quality Care Inc. $FVE
Five Star Quality Care, Inc(FVE) is a national healthcare and senior living provider, offers the highest quality of care and service. Five Star has two major operating divisions: Five Star Senior Living and Five Star Rehabilitation Services. The Five Star Senior…
BioDelivery Sciences Primed To Grab Its Share Of The $1.5 Billion Opioid Market
These days, prescription drugs have become a source for legal and illegal abuse. This abuse can lead to a medical diagnosis called opioid dependence, which is when a patient that is addicted to opioids such as morphine, hydrocodone, oxycodone, or…
Mannkind Thesis – Bearish $MNKD
In my opinion, investors need to be careful of the current MNKD stock run up. It’s likely it’s manipulation being pulled off by the warrant holders in order for them to cash out with good profit. Company has ZERO chance…
Amarin Basic Company Thesis – Bearish 5/25/13 $AMRN
My basic opinion on Amarin. Like Vascepa, hate management and company structure. My opinion long term is bearish.
Biosciences Delivery Systems+ Antares Chart Update: 5/25/13 $BDSI, $ATRS
My opinion on Antares BDSI pasy trading action and for the future.
I bought BioDelivery Sciences (BDSI) on Bullish Chart: Solid Small Cap Spec Investment.
BioDelivery Sciences (BDSI) focuses on developing and commercializing products in the areas of pain management and oncology supportive care. The company uses its patented BioErodible MucoAdhesive (BEMA) and Bioral cochleate drug delivery technologies in the development of its products. …
Antares Pharma Chart Update and Analysis, May 22
Antares Pharma Chart Update and Analysis, May 22
I bought Antares @ $3.95, I see a move to $4.35 short term
I bought Antares @ $3.95, I see a move to $4.35 short term. I think from tomorrow to beginning of next week, we see the move. From above, we can clearly see a tightening wedge forming in the chart. I…